You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 5,238,924


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,238,924
Title: Treatment of renal diseases with ace inhibitors
Abstract:There is disclosed the use of angiotensin converting enzyme (ACE) inhibitors to alter the progression of renal diseases by affecting intraglomerular hemodynamics and proteinuria; i.e., affecting blood pressure within the functioning, filtering tissue of the kidney and the quantity of albumin in the urine.
Inventor(s): Smith; Ronald D. (Worchester, PA)
Assignee: Merck & Co., Inc. (Rahway, NJ) Brigham & Women's Hospital (Boston, MA)
Application Number:07/721,790
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 5,238,924

Introduction

Understanding the scope and claims of a patent is crucial for inventors, patent attorneys, and businesses alike. This article delves into the details of United States Patent 5,238,924, exploring its claims, the patent landscape, and the tools and resources available for such analyses.

Patent Overview

United States Patent 5,238,924, though not specifically detailed in the provided sources, can be analyzed using general principles and tools available for patent research.

Patent Claims

Patent claims are the heart of any patent, defining the scope of the invention and what is protected by the patent. Here are some key points to consider:

Claim Structure

Patent claims typically follow a specific structure, including independent and dependent claims. Independent claims stand alone and define the invention broadly, while dependent claims refer back to and further limit the independent claims[3].

Claim Types

There are different types of claims, such as utility, design, and plant claims. Utility claims cover functional aspects of the invention, design claims cover the ornamental design of a functional item, and plant claims cover new and distinct plant varieties[1].

Determining Inventorship

Correctly identifying the inventors is vital for the validity and enforceability of a patent.

True and Only Inventors

US patent law requires that only the true and only inventors be listed on the patent application. This involves identifying those who conceived the idea and reduced it to practice[2].

Consequences of Incorrect Inventorship

Incorrect or deceptive inventorship can render a patent unenforceable. It is crucial to ensure that all inventors are properly identified to avoid legal issues[2].

Patent Landscape Analysis

Analyzing the patent landscape involves understanding the broader context in which the patent exists.

Global Dossier

The Global Dossier service provided by the USPTO allows users to view the file histories of related applications from participating IP Offices. This can help in understanding the global patent family and any office actions related to the patent[1].

Common Citation Document (CCD)

The CCD consolidates prior art citations from multiple IP offices, providing a single point of access to citation data. This tool is essential for understanding the prior art landscape and how different offices have treated similar inventions[1].

Tools and Resources for Patent Analysis

USPTO Public Search Facility

The USPTO Public Search Facility in Alexandria, VA, and the Patent and Trademark Resource Centers (PTRCs) across the country provide access to patent and trademark information. These resources are invaluable for conducting thorough patent searches[1].

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset offers detailed information on claims from US patents and applications. This dataset can be used to analyze claim-level statistics and document-level statistics, providing insights into patent scope and trends[3].

Case Studies and Examples

To illustrate the importance of thorough patent analysis, consider the following example:

Incorrect Inventorship Case

In cases like Frank’s Casing Crew v. PMR Technologies, incorrect inventorship led to the patent being deemed unenforceable due to deceptive intent. This highlights the critical need for accurate inventorship determination[2].

Legal and Policy Considerations

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could simplify and reduce the costs associated with patent litigation. This is an area of ongoing research and policy debate[5].

Key Takeaways

  • Accurate Inventorship: Correctly identifying the true and only inventors is crucial for the validity and enforceability of a patent.
  • Patent Claims: Understanding the structure and types of claims is essential for defining the scope of the invention.
  • Patent Landscape: Tools like the Global Dossier and CCD help in analyzing the broader patent landscape.
  • Resources: Utilize the USPTO Public Search Facility, PTRCs, and the Patent Claims Research Dataset for comprehensive patent analysis.

FAQs

Q: What is the importance of correct inventorship in a patent application? A: Correct inventorship is crucial because incorrect or deceptive inventorship can render the patent unenforceable.

Q: How can I access the file histories of related patent applications globally? A: The Global Dossier service provided by the USPTO allows access to the file histories of related applications from participating IP Offices.

Q: What is the Common Citation Document (CCD)? A: The CCD consolidates prior art citations from multiple IP offices, providing a single point of access to citation data.

Q: Where can I find detailed information on patent claims and their statistics? A: The USPTO's Patent Claims Research Dataset offers detailed information on claims from US patents and applications.

Q: Is there a proposal for a small claims patent court in the United States? A: Yes, there have been studies and discussions on the feasibility of a small claims patent court to simplify and reduce the costs associated with patent litigation.

Sources

  1. USPTO - Search for patents - USPTO
  2. Oregon State University - Determining Inventorship for US Patent Applications
  3. USPTO - Patent Claims Research Dataset
  4. Google Patents - EP1253945A2 - Combinaisons d'inhibiteurs d'ace ...
  5. ACUS - U.S. Patent Small Claims Court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,238,924

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,238,924

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 4178185 ⤷  Subscribe
Australia 569789 ⤷  Subscribe
Denmark 175190 ⤷  Subscribe
Denmark 197985 ⤷  Subscribe
European Patent Office 0160307 ⤷  Subscribe
Japan H075482 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.